On Thursday 16 April, Christophe Clergeau, vice-chair of the S&D Group in European Parliament, said that he was confident of obtaining sufficiently broad support within Parliament to improve the draft regulation on new genomic techniques (NGTs), particularly regarding the issue of patents.
He explained to a group of journalists that he intended to submit a package of three amendments to the other European Parliament political groups.
The text on NGTs, along with any amendments, is expected...